Teicoplanin versus flucloxacillin in the treatment of infection following burns

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 3, 1997, Pages 383-392

  Steer, J A ^a,b   Papini, R P G ^a,b   Wilson, A P R ^a   McGrouther, D A ^a   Parkhouse, N ^b,c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

^c QUEEN VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCLOXACILLIN; GENTAMICIN; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BURN INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RASH;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BURNS; CHILD; CHILD, PRESCHOOL; FEMALE; FLOXACILLIN; GRAM-POSITIVE BACTERIA; HUMANS; INFANT; MALE; MIDDLE AGED; PENICILLINS; PROSPECTIVE STUDIES; TEICOPLANIN;

EID: 0031002754     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.3.383     Document Type: Article

References (24)

1. Nakhla, L. S. & Sanders, R. (1991). Microbiological aspects of burns at Mount Vernon Hospital, UK. Bums 17, 309-12.
2. Papini, R. P. G., Wilson, A. P. R., Steer, J. A., McGrouther, D. A. & Parkhouse, N. (1995). Wound management in burn centres in the United Kingdom. British Journal of Surgery 82, 505-9.
3. Papini, R. P. G., Wilson, A. P. R., Steer, J. A., McGrouther, D. A. & Parkhouse, N. (1995). Wound management in burn centres in Europe. European Journal of Plastic Surgery 18, 63-7.
4. Dacso, C. C., Luterman, A. & Curreri, P. W. (1987). Systemic antibiotic treatment in burned patients. Surgical Clinics of North America 67, 57-68.
5. Boucher, B. A., Kuhl, D. A. & Hickerson, W. L. (1992). Pharmacokinetics of systemically administered antibiotics in patients with thermal injury. Clinical infectious Diseases 14, 458-63.
6. Potel, G., Moutet, J., Bernareggi, A., Le Normand, Y., Meigner, M. & Baron, D. (1990). Pharmacokinetics of teicoplanin in burn patients. Scandinavian Journal of infectious Diseases, Suppl. 72, 29-34.
7. Steer, J. A., Papini, R. P. G., Wilson, A. P. R., Dhilion, S., Hichens, M. F., McGrouther, D. A. et al. (1996). Pharmacokinetics of a single dose of teicoplanin in burn patients. Journal of Antimicrobial Chemotherapy 37, 545-53.
8. Campoli-Richards, D. M., Brogden, R. N. & Faulds, D. (1990). Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 40, 449-86.
9. Steer, J. A., Papini, R. P. G., Wilson, A. P. R., McGrouther, D. A., Nakhla, L. S. & Parkhouse, N. (1997). A randomized placebo controlled trial of teicoplanin in the antibiotic prophylaxis of infection following manipulation of burns. British Journal of Surgery, In press.
10. Pruitt, B. A. (1984). The diagnosis and treatment of infection in the burn patient. Burns, Including Thermal Injury 11, 79-91.
11. Demling, R. H. (1985). Burns. New England Journal of Medicine 313, 1389-98.
12. McManus, A. T., Kim, S. H., McManus, W. G., Mason, A. D. & Pruitt, B. A. (1987). Comparison of quantitative microbiology and histopathology in divided burn-wound biopsy specimens. Archives of Surgery 122, 74-6.
13. Steer, J. A., Papini, R. P. G., Wilson, A. P. R., McGrouther, D. A. & Parkhouse, N. (1996). Quantitative microbiology in the management of burn patients. I. Correlation between quantitative and qualitative burn wound biopsy culture and surface alginate swab culture. Burns 22, 173-6.
14. Steer, J. A., Papini, R. P. G., Wilson, A. P. R., McGrouther, D. A. & Parkhouse, N. (1996). Quantitative microbiology in the management of burn patients. II. Relationship between bacterial counts obtained by burn wound biopsy culture and surface alginate swab culture, with clinical outcome following burn surgery and change of dressings. Burns 22, 177-81.
15. Patton, K. R., Beg, A., Felmingham, D., Ridgway, G. L. & Grüneberg, R. N. (1987). Determination of teicoplanin concentration in serum using a bioassay technique. Drugs Under Experimental and Clinical Research 13, 547-50.
16. Armitage, P. & Berry, G. (1987). Statistical Methods in Medical Research, 2nd edn. Blackwell Scientific Publications, London.
17. Heimbach, D. M. (1984). Cefsulodin therapy for infections due to Pseudomonas aeruginosa in patients with burns. Reviews of Infectious Diseases 6, Suppl. 3, S744-50.
18. Periti, P., Stringa, G., Donati, L., Mazzei, T., Mini, E. & Novelli, A. (1992). Teicoplanin: its role as systemic therapy of burn infections and as prophylaxis for orthopaedic surgery. European Journal of Surgery, Suppl. 567, 3-8.
19. Rio, Y., Giorgi, C., Schockmel, G., Didion, J., Jurin, F., Meley, M. et al. (1987). Traitement des septicémies et infections cutanées chez le brûlé par la teicoplanine. Pathologie Biologie 35, 603-7.
20. Theron, E. J. & Nel, C. J. C. (1983). Treatment of septic burns with a third-generation cephalosporin (cefatriaxon). South African Medical Journal 64, 816-7.
21. Kunst, M. W. (1987). Ceftazidime treatment in severe burns. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery 21, 281-2.
22. Culbertson, G. R., McManus, A. T., Conarro, P. A., McManus, W. F., Mason, A. D. & Pruitt, B. A. (1987). Clinical trial of imipenem/cilastatin in severely burned and infected patients. Surgery, Gynecology and Obstetrics 165, 25-8.
23. Wilson, A. P. R., Grüneberg, R. N. & Neu, H. (1994). A critical review of the dosage of teicoplanin in Europe and the USA. International Journal of Antimicrobial Agents 4, Suppl. 1, S1-30.
24. Law, E. J., Blecher, K. & Still, J. M. (1994). Enterococcal infections as a cause of mortality and morbidity in patients with burns. Journal of Burn Care and Rehabilitation 15, 236-9.